Device establishmentActive, RegisteredFDA warning letter on file

OWLET BABY CARE

OWLET BABY CARE is an FDA-registered device establishment (FEI 3012977166) located in Lehi, Utah. The facility is active, registered. FDA has issued 1 warning letter(s) to this facility.

FDA warning letter

Oct 5, 2021
Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA) Adulterated Device

A warning letter is FDA's formal notice of significant violations that require prompt correction. It can hold up product approvals, trigger import alerts, and put supply agreements at risk until the issues are resolved and FDA closes it out.

Establishment record

FEI Number
3012977166
Address
2940 West Maple Loop Dr. Suite 203, Lehi, Utah
Establishment type
Device establishment
Products / operations
Cardiovascular, Develop Specifications But Do Not Manufacture At This Facility, Complaint File Establishment per 21 CFR 820.198
Registration status
Active, Registered

Verify this record in FDA source data ›

Inspection history

Inspections on file
None on file
Form 483 observations
None on file

FDA publishes only a subset of inspection records and Form 483s, so "None on file" is not a guarantee of a clean inspection history.

FDA record timeline

Warning letter
Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA) Adulterated Device
Source ›

Combined chronology of the public records shown on this page. FDA coverage varies by dataset and year.

Questions

Is OWLET BABY CARE registered with the FDA?

Yes. OWLET BABY CARE is an FDA-registered device establishment (FEI 3012977166) in Lehi, Utah. Its current registration status is Active, Registered.

Has OWLET BABY CARE received an FDA warning letter?

Yes. FDA issued a warning letter to OWLET BABY CARE; the most recent is dated Oct 5, 2021 (Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA) Adulterated Device).

What does OWLET BABY CARE do?

OWLET BABY CARE's FDA-registered operations are: Cardiovascular, Develop Specifications But Do Not Manufacture At This Facility, Complaint File Establishment per 21 CFR 820.198.

Related facilities

Source: FDA public data · status as of 2026-08-22

The Quality Brief

Every new FDA drug and device warning letter and recall, summarized once a week. Free.